Caspase-8 as a therapeutic target in cancer
- 1 May 2013
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 332 (2) , 133-140
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- CD95 promotes tumour growthNature, 2010
- Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 ActivationJournal of Biological Chemistry, 2010
- Rab5 Mediates Caspase-8–promoted Cell Motility and MetastasisMolecular Biology of the Cell, 2010
- Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinomaThe Prostate, 2009
- Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubulesOncogene, 2009
- FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cellsProceedings of the National Academy of Sciences, 2008
- Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor CellsJournal of Biological Chemistry, 2008
- Identification of a Critical Tyrosine Residue in Caspase 8 That Promotes Cell MigrationJournal of Biological Chemistry, 2008
- The Death Domain Superfamily in Intracellular Signaling of Apoptosis and InflammationAnnual Review of Immunology, 2007
- Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppressionThe EMBO Journal, 2006